Cargando…
Premature Ventricular Contractions and Cardiomyopathy while on Ofatumumab for Treatment of Chronic Lymphocytic Leukaemia
Ofatumumab is a monoclonal antibody used in the treatment of recurrent and progressive chronic lymphocytic leukaemia (CLL) and was recently approved for the treatment of multiple sclerosis. We describe the case of a 68-year-old man who presented with complaints of irregular pulse readings while unde...
Autores principales: | Odeyinka, Oladipo, Collins, Mitchell, Sunnaa, Michael, Venugopal, Parameswaran, Okwuosa, Tochukwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728215/ https://www.ncbi.nlm.nih.gov/pubmed/36506740 http://dx.doi.org/10.12890/2022_003625 |
Ejemplares similares
-
Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
por: Planek, Maria Isabel Camara, et al.
Publicado: (2020) -
Premature ventricular contraction-induced dilated cardiomyopathy: a case report
por: Sen, Jonathan, et al.
Publicado: (2019) -
Role of ofatumumab in treatment of chronic lymphocytic leukemia
por: Veliz, Marays, et al.
Publicado: (2011) -
Left ventricular dyssynchrony as marker of early dysfunction in premature ventricular contraction-induced cardiomyopathy
por: Kowlgi, Gurukripa N., et al.
Publicado: (2022) -
The Emerging Role of Ofatumumab in the Treatment of Chronic Lymphocytic Leukemia
por: Nabhan, Chadi, et al.
Publicado: (2011)